Qube Research & Technologies (QRT)
ELV icon

Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.56M Buy
9,200
+1,600
+21% +$593K ﹤0.01% 1803
2026
Q1 		$2.22M Sell
7,600
-12,300
-62% -$4.04M ﹤0.01% 2104
2025
Q4 		$6.98M Sell
19,900
-11,100
-36% -$3.75M 0.01% 1568
2025
Q3 		$10M Buy
31,000
+10,100
+48% +$3.14M 0.01% 1323
2025
Q2 		$8.13M Buy
20,900
+7,900
+61% +$3.18M 0.01% 1415
2025
Q1 		$5.65M Sell
13,000
-6,900
-35% -$2.77M 0.01% 1456
2024
Q4 		$7.34M Sell
19,900
-43,000
-68% -$18M 0.01% 1281
2024
Q3 		$32.7M Sell
62,900
-6,500
-9% -$3.47M 0.05% 479
2024
Q2 		$37.6M Buy
69,400
+11,900
+21% +$6.29M 0.06% 382
2024
Q1 		$29.8M Buy
57,500
+45,200
+367% +$22.5M 0.05% 446
2023
Q4 		$5.8M Buy
+12,300
New +$5.69M 0.01% 962

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELV Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Elevance Health (ELV) stake by 468% in Q2 2026, buying an estimated $196M and bringing the position to 640,181 shares worth $248M. The position accounts for 0.23% of the portfolio, ranked #95.

Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 26 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Qube Research & Technologies (QRT) held 640,181 shares of Elevance Health worth $248M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 527,464 Elevance Health shares in Q2 2026, an estimated $196M.
  • Elevance Health made up 0.23% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #95 holding.
  • Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 26 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.